NovoCure Ltd (NVCR)
12.05
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
12.05
0.00 (0.00%)
After-Hours: 20:00
NovoCure Profit Margin (Quarterly): -35.19% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -35.19% |
| September 30, 2023 | -38.87% |
| June 30, 2023 | -45.55% |
| March 31, 2023 | -43.43% |
| December 31, 2022 | -29.05% |
| September 30, 2022 | -20.29% |
| June 30, 2022 | -17.04% |
| March 31, 2022 | -3.38% |
| December 31, 2021 | -19.86% |
| September 30, 2021 | -9.82% |
| June 30, 2021 | -10.97% |
| March 31, 2021 | -3.06% |
| December 31, 2020 | 3.42% |
| September 30, 2020 | 7.00% |
| June 30, 2020 | 1.43% |
| March 31, 2020 | 3.88% |
| December 31, 2019 | 4.29% |
| September 30, 2019 | 2.10% |
| June 30, 2019 | -1.46% |
| Date | Value |
|---|---|
| March 31, 2019 | -16.57% |
| December 31, 2018 | -22.43% |
| September 30, 2018 | -18.06% |
| June 30, 2018 | -25.21% |
| March 31, 2018 | -39.76% |
| December 31, 2017 | -20.40% |
| September 30, 2017 | -22.95% |
| June 30, 2017 | -55.18% |
| March 31, 2017 | -51.73% |
| December 31, 2016 | -73.30% |
| September 30, 2016 | -155.2% |
| June 30, 2016 | -226.6% |
| March 31, 2016 | -271.5% |
| December 31, 2015 | -265.9% |
| September 30, 2015 | -290.7% |
| June 30, 2015 | -448.7% |
| March 31, 2015 | -446.9% |
| December 31, 2014 | -602.9% |
| September 30, 2014 | -418.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-45.55%
Minimum
Jun 2023
7.00%
Maximum
Sep 2020
-13.47%
Average
-9.82%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
| AtriCure Inc | -9.19% |
| NeuroMetrix Inc | -125.2% |
| Repligen Corp | -16.37% |
| Teleflex Inc | 4.02% |
| Perspective Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -50.62% |
| Return on Assets | -17.79% |
| Return on Invested Capital | -21.21% |
| Gross Profit Margin (Quarterly) | 75.67% |
| Operating Margin (Quarterly) | -38.66% |
| Return on Net Operating Assets | -94.21% |